These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6437133)

  • 21. [Bacteria and resistance to antibiotics in acute otitis media in paediatrics, depending on the geographical origin].
    Bidet P; Doit C; Bingen E
    Presse Med; 2003 Nov; 32(37 Pt 1):1752-9. PubMed ID: 14663392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacodynamic parameters to evaluate antibiotic cover as empirical treatment].
    Aguilar L; Granizo JJ
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):165-6. PubMed ID: 21334784
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
    Soriano F; Parra A; Cenjor C; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Ponte C
    J Infect Dis; 2000 Feb; 181(2):646-52. PubMed ID: 10669350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of drug-resistant Streptococcus pneumoniae for otitis media.
    Poole MD
    Pediatr Infect Dis J; 1998 Oct; 17(10):953-6. PubMed ID: 9802652
    [No Abstract]   [Full Text] [Related]  

  • 25. Erythromycin-sulfisoxazole vs amoxicillin in the treatment of acute otitis media in children. A double-blind, multiple-dose comparative study.
    Rodriguez WJ; Schwartz RH; Sait T; Khan WN; Chhabra OP; Chang MJ; Reddy S; Marks LA; Gold AJ
    Am J Dis Child; 1985 Aug; 139(8):766-70. PubMed ID: 3895889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penicillin V treatment of experimental pneumococcal otitis media prevents mucosal changes.
    Hermansson A; Prellner K; Hellström S
    Acta Otolaryngol Suppl; 1992; 492():125-8. PubMed ID: 1632237
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
    Sher L; Arguedas A; Husseman M; Pichichero M; Hamed KA; Biswas D; Pierce P; Echols R
    Pediatr Infect Dis J; 2005 Apr; 24(4):301-8. PubMed ID: 15818288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Yokoyama M
    Jpn J Antibiot; 2001 May; 54 Suppl B():88-90. PubMed ID: 12638152
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain.
    Isla A; Trocóniz IF; Canut A; Labora A; Martín-Herrero JE; Pedraz JL; Gascón AR
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):167-73. PubMed ID: 21334779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
    Sakata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of antimicrobial treatments in children with acute otitis media in Spain: a pharmacokinetic-pharmacodynamic (PK/PD) approach.
    Beobide I; Canut A; Gascón AR; Isla A; García-Rey C; De La Maza I; Labora A; Pedraz JL
    J Chemother; 2005 Dec; 17(6):628-35. PubMed ID: 16433193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Only the pneumococcus..
    Olson LC; Jackson MA
    Pediatr Infect Dis J; 1999 Oct; 18(10):849-50. PubMed ID: 10530577
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High-dose cefditren therapy for children with acute otitis media that had Streptococcus pneumoniae and haemophilus influenzae isolated from the nasopharynx].
    Ito M; Furukawa M
    Jpn J Antibiot; 2001 May; 54 Suppl B():37-8. PubMed ID: 12638141
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential role of fluoroquinolone therapy in childhood otitis media.
    Dagan R; Arguedas A; Schaad UB
    Pediatr Infect Dis J; 2004 May; 23(5):390-8. PubMed ID: 15131460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An open randomized trial, Pediazole versus cefaclor in the treatment of acute otitis media in children].
    Cohen R; de La Rocque F; Boucherat M; Bedbeder P; Bouhanna CA; Geslin P; Peynegre R; Reinert P
    Ann Pediatr (Paris); 1991 Feb; 38(2):115-9. PubMed ID: 2029123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriology of acute otitis media in adults.
    Celin SE; Bluestone CD; Stephenson J; Yilmaz HM; Collins JJ
    JAMA; 1991 Oct 23-30; 266(16):2249-52. PubMed ID: 1920724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotics for recurrent acute otitis media in infants under two (author's transl)].
    Bláhová O; Drastík J
    Z Laryngol Rhinol Otol; 1973 Nov; 52(11):802-7. PubMed ID: 4149361
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical implications of antibiotic resistance for management of acute otitis media.
    Klein JO
    Pediatr Infect Dis J; 1998 Nov; 17(11):1084-9; discussion 1099-100. PubMed ID: 9850003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.